1. Xu, J., and Zhang, Y. (2020). Traditional Chinese medicine treatment of COVID-19. Complement Ther. Clin. Pract. 39, 101165..

1. Xu, J., and Zhang, Y. (2020). Traditional Chinese medicine treatment of COVID-19. Complement Ther. Clin. Pract. 39, 101165..

2. Асқаров И.Р. Табобат қомуси. Т.: "Мумтозсўз". - 2019. - Б. 1142. (Askarov I.R. Folk medical encyclopedia. Т.: "Mumtoz suz", 2019, 1142)

3. Асқаров И.Р. Сирли табобат. – Т.: Фан ва технологиялар нашриёт-матбаа уйи. 2021. – Б. 1084. (Askarov I.R. Mysterious folk medicine. T.: Fan va texnologiyalar nashriyot-matbaa uyi, 2021, 1084)

4. Li, G., et al.. “Chapter 6: artemisinin and derivatives: clinical studies,” in Artemisinin-based and other Antimalarials: detailed account of studies by Chinese scientists who discovered and developed them. Cambridge, MA: Academic Press, 2018., 353–413.

5. Duc, D. D., et al. The pharmacokinetics of a single dose of artemisinin in healthy Vietnamese subjects. Am. J. Trop. Med. Hyg. 1994, 51 (6), 785–790.

6. WHO (2020). Guidelines for the treatment of malaria, 2nd edn. Geneva: World Health Organization Available at: http://apps.who.int/medicinedocs/en/m/abstract/Js19105en/.

8. Sehailia, M., and Chemat, S. (2020). In-silico studies of antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing, «of artenimol for COVID-19. ChemRxiv.».

9. Li, G., Yuan, M., Li, H., Deng, C., Wang, Q., Tang, Y., et al. (2021). Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial. Int. J. Antimicrob. Agents 57, 106216..

10. Health Care (2020). MGC Pharmaceutical’s (ASX:MXC) ArtemiC combats COVID-19. https://themarketherald.com.au/mgc-pharmaceuticals-asxmgc-artemic-combats-covid-19-2020-12-15/.

11. Lin, Y., Wu, F., Xie, Z., Song, X., Zhu, Q., Wei, J., et al. (2020). [Clinical study of artesunate in the treatment of coronavirus disease 2019], Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 32 (4), 417–420..

12. Uckun, F. M. Reducing the fatality rate of COVID-19 by applying clinical insights from immuno-oncology and lung transplantation. Front. Pharmacol. 2020 b, 11, 796.

13. Коновалов Д.А., Хамилонов А.А. Биологически активные соединения полыни однолетней. Эфирноемасло. ФармацияифармакологияТ. 4 № 4, 2016, 4-33. (Konovalov D.A., Khamilonov A.A. Biologically active compounds of wormwood annual. Essential oil. Pharmacy and pharmacology T.4, Vol 4, 2016, 4-33)

14. Woodrow CJ, Haynes RK, Krishna S. Artemisinins. Postgrad Med J. 2005;81(952):71-78.

15. Asqarov I.R., Abdulloyev O.Sh., Fozilova G.E. Bir yillik shuvoqning kimyoviy tarkibi va shifobaxsh xususiyatlari. Материалы международной научно-практической онлайн- конференции с участием международных партнерских вузов от 6-7 мая 2021 года по теме Народная медицина: прошлое и будущее. Фергана 2021. С. 27-28. (15. Askarov I.R., Abdulloyev O.Sh., Fozilova G.E. Chemical composition and medicinal properties of annual wormwood. Materials of the international scientific and practical online conference with the participation of international partner universities from May 6-7, 2021 on the topic Traditional medicine: past and future. Fergana 2021. P. 27-28)

7. Efferth, T., et al. The antiviral activities of artemisinin and artesunate. Clin. Infect Dis. 2008, 47 (6), 804–811.